Skip to main content

2 Result(s)

within Yifang Shui Remove this filter

and

  1. No Access

    Article

    PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model

    In the tumor microenvironment (TME), one of the major functions of tumor-recruited CD11b+ cells are the suppression of the T-cell-mediated anti-tumor immune response. β-glucan could convert the phenotype of tumor...

    **n Hu, Yifang Shui, Hiroshi Hirano, Kisato Kusano… in Cancer Immunology, Immunotherapy (2023)

  2. Article

    Open Access

    A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients

    Programmed death-ligand 1 (PD-L1) was the first identified ligand of programmed death-1 (PD-1). PD-1/PD-L1 interactions inhibit T cell-mediated immune responses, limit cytokine production, and promote tumor im...

    **g Yang, Meilian Dong, Yifang Shui, Yue Zhang, Zhigang Zhang… in Cancer Cell International (2020)

    Download PDF (1875 KB) View Article